Skip to main content
SpringerLink
Log in

The value of data mining as a method of pharmacovigilance

  • Non-clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Bailey S, Singh A, Azadian R, Huber P, Blum M.Prospective data mining of six products in the US FDA Adverse Event Reporting System: disposition of events identified and impact on product safety profiles. Drug Safety 33: 139-146, No. 2, 2010

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The value of data mining as a method of pharmacovigilance. React. Wkly. 1289, 5 (2010). https://doi.org/10.2165/00128415-201012890-00013

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201012890-00013

Keywords

Search

Navigation